Related Experiment Video

Updated: Mar 24, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

Developments in miRNA gene signaling pathways in pancreatic cancer

Christina Vorvis1, Marina Koutsioumpa1, Dimitrios Iliopoulos1

  • 1Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.

Future Oncology (London, England)
|March 18, 2016
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in pancreatic cancer, influencing signaling pathways and disease progression. This review explores their role in pancreatic ductal adenocarcinoma and potential as biomarkers and therapeutics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic cancer is a leading cause of cancer death globally with poor prognosis.
  • Limited understanding of molecular pathogenesis hinders effective treatment.
  • MicroRNAs (miRNAs) are implicated in pancreatic cancer initiation and progression.

Purpose of the Study:

  • To review the latest advances in understanding the roles of miRNAs in pancreatic ductal adenocarcinoma (PDAC).
  • To explore the involvement of miRNAs in key signaling pathways like KRAS and Notch.
  • To discuss the potential of miRNAs as biomarkers and therapeutic agents for PDAC.

Main Methods:

  • Literature review of recent studies on miRNAs in pancreatic cancer.
  • Analysis of miRNA deregulation in PDAC.
  • Focus on miRNA regulation of signaling pathways, cell cycle, and transcription factors.

Main Results:

  • miRNAs are deregulated in pancreatic cancer, impacting disease initiation and aggressiveness.
  • miRNAs regulate critical signaling pathways (e.g., KRAS, Notch) involved in PDAC.
  • miRNAs influence cell cycle events and transcription factor expression.

Conclusions:

  • miRNAs play significant roles in pancreatic ductal adenocarcinoma pathogenesis.
  • miRNAs show promise as diagnostic biomarkers for early detection.
  • miRNA-based therapeutics offer a potential new avenue for treating pancreatic cancer.
Keywords:
antisense oligonucleotidesmiRNAspancreatic cancer

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

492

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K